The European Society of Cataract and Refractive Surgeons (ESCRS) 2023 conference unfolded at Vienna’s Messe Wien, Austria. Today, September 8th, 2023, was marked by a series of insightful presentations and electronic poster sessions by ELZA’s surgeons and scientists. Here’s a comprehensive overview of the day’s significant contributions.

 

1. Epithelium-on CXL Advancements | Room A2, 15:05 – 15:15:
Prof. Farhad Hafezi, whose work has consistently been at the forefront of ophthalmological advancements, provided an in-depth analysis of the latest developments in epithelium-on CXL. This presentation highlighted the recent advancements and their implications for the broader field.

 

2. Mastering DMEK Complications | Room A3, 18:20 – 18:33:
Dr. Lamis Baydoun gave a great presentation centered on the complexities associated with Descemet’s Membrane Endothelial Keratoplasty (DMEK). Her systematic approach and analysis provided clarity on navigating these challenges, emphasizing the manageability of DMEK complications with the right techniques and understanding.

 

3. E-Poster Sessions:

  • An e-poster by Prof. Farhad Hafezi on Successfully Combining Riboflavin/UV-A And Rose Bengal/Green Light Pack-Cross-Linking in Acanthamoeba Keratitis was featured, underscoring the potential benefits of this combined therapeutic approach in treating Acanthamoeba Keratitis. This dual chromophore/light combination PACK-CXL treatment gave excellent outcomes, and in a shorter period that typical standard-of-care CXL, and may represent a great step forward in how AK is treated.
  • Dr. Nan-Ji Lu’s e-poster introduced a New Biomechanical Index for Post-Laser Vision Correction Ectasia Diagnosis. This research sheds light on the prospects of enhancing diagnostic accuracy for post-laser vision complications, which is something of intense interest to all refractive surgeons, as improving the accuracy of these indicies all helps to further enhance the safety of the already incredibly safe field of refractive laser surgery.
  • Furthermore, Dr. M. Enes Aydemir presented an e-poster detailing the Endothelial Safety of a New 10 J/cm2 High-Fluence CXL Protocol for Progressive Keratoconus. This research provides a preliminary yet critical exploration into improving treatment protocols for progressive keratoconus patients where the aim is Dresden protocol-like strengthening of the cornea can be achieved in a shorter time – but without risking damage to the corneal endothelium.